West Pharmaceutical Services Inc.

WST | NYSE

Price Alert Chart Builder DCF Calculator

$363.69

+$1.38 (+0.38%)

Sep 21, 2026, 10:22 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

+0.38%

(1D)

Rating

Updated: Aug 21, 2026

49.5

Fundamentals Average

Market Sentiment Bullish

Moat Narrow

Full Analysis

Key Statistics

Market Data

Market Cap $25.6B

1D Range

361.63 365.01

52W Range

223.83 386

Valuation (TTM)

PE 46.31

PB 8.52

EV/EBITDA 30.77

Valuation (NTM)

Forward PE 36.01

Forward PEG 4.04

Price Target $407

Cash Flow

FCF Yield 1.7%

SBC Adj. FCF Yield 1.6%

SBC Impact -7.5%

Margins

Gross Margin 36.8%

Operating Margin 20.6%

FCF Margin 13.1%

Growth (CAGR)

Revenue 3Y | 5Y 5.1% | 5.7%

Dil EPS 3Y | 5Y 4.5% | 2.7%

FCF 3Y | 5Y 3.3% | 8.7%

Returns

ROA 13.9%

ROE 18.5%

ROIC 15.8%

Financial Health

Net Cash

$123.7M

Current Ratio 2.82

Interest Coverage 6,865.00

Dividends

Div Yield 0.24%

Payout Ratio 11.3%

FCF Payout Ratio 14.3%

All Key Statistics

Loading financial charts...

Profile

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other...

Sector Healthcare

Industry Medical - Instruments & Supplies

Employees 10,800

IPO Date Mar 16, 1980

Website www.westpharma.com

Fiscal Year January - December

Full Company Profile

Latest News

3 days ago · zacks.com

Reasons to Add West Pharmaceutical Stock to Your Portfolio Now

West Pharmaceutical's biologics exposure, Annex 1 projects and delivery-device growth support prospects despite near-term headwinds.

7 days ago · seekingalpha.com

West Pharmaceutical Services, Inc. (WST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

11 days ago · seekingalpha.com

West Pharmaceutical Services, Inc. (WST) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

17 days ago · defenseworld.net

Analyzing West Pharmaceutical Services (NYSE:WST) and Acutus Medical (NASDAQ:AFIB)

West Pharmaceutical Services (NYSE: WST - Get Free Report) and Acutus Medical (NASDAQ: AFIB - Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation and dividends. Volatility and Risk West Pharmaceutical Services has

26 days ago · prnewswire.com

West to Participate in Upcoming Investor Conferences

EXTON, Pa., Aug. 26, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following upcoming investor conferences: Wells Fargo Annual Healthcare Conference on Thursday, September 10, 2026 at 8:45 a.m. EDT in Everett, MA Morgan Stanley Annual Global Healthcare Conference on Monday, September 14, 2026 at 8:30 a.m.

1 month ago · zacks.com

WST Stock Surges 38.1% Since March-End: What's Fueling the Rally?

West Pharmaceutical Services has surged 38.1% since March-end as HVP demand, GLP-1 growth and productivity gains fuel the rally.

1 month ago · zacks.com

West Pharmaceutical (WST) Upgraded to Buy: Here's Why

West Pharmaceutical (WST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).